Davipharm

The final days of the year are prime to look back, and ahead.

Here is our 2023 recap:

➡️ DAVIPHARM, A MEMBER OF ADAMED GROUP

April 2023: Adamed Pharma acquired remaining 30% of Davipharm, becoming its 100% shareholder, with ambition to become a top drug manufacturer in Vietnam, providing high-quality, affordable drugs for local patients and for export.

➡️ OPERATION HIGHLIGHTS

Production volume reached 640 million units; 8 products in tech-transfer.

➡️ SALES & MARKETING EVENTS

October 24-26, 2023: Davipharm for the first time joined CPHI, the largest annual international pharmaceutical event.

April 14-16, 2023: Key partner of one of biggest national annual scientific conferences, “Update on Diagnosis and Treatment in Geriatrics” in Danang by HCMC Geriatric Association

➡️ COMMUNITY HEALTHCARE PREVENTION

Over 10,000 people participated in free Non-Communicable Disease (NCD) health screenings; 406 doctors trained on NCDs and 1.6 million Vietnamese citizens educated to prevent and identify the early symptoms of NCDs.

➡️ ADAMED SMARTUP

4th edition of this scientific program completed with 3 winners joining the educational summer camp in Poland; 200 students enrolled in the 5th edition of ASU in Vietnam.

Thank you all for being part of our 2023 journey and success.

Looking ahead to 2024, its ambitious yet achievable goals and our commitment to excellence.

Wishing you happiness and prosperity, good health and best of luck. Happy New Year!